Recent Advances in Definitive Radiotherapy for Prostate Cancer - European Medical Journal
×

Browse

Recent Advances in Definitive Radiotherapy for Prostate Cancer

| Download as | PDF
Authors:
*Michael Pinkawa
Disclosure:

No potential conflict of interest.

Received:
27.10.14
Accepted:
17.12.14
Citation
EMJ Oncol. ;3[1]:41-48.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Definitive radiation therapy is a well-recognised curative treatment option for localised prostate cancer. A suitable technique, dose, target volume, and the option of a combination with androgen deprivation therapy needs to be considered. An optimal standard external beam radiotherapy includes currently the intensity-modulated and image-guided radiotherapy techniques with total doses of ≥76-78 Gy in conventional fractionation. Data from several randomised studies increasingly support the rationale for hypofractionated radiotherapy. A simultaneous integrated boost with dose escalation focused on a computed tomography/positron emission tomography or magnetic resonance imaging/magnetic resonance spectroscopy detected malignant lesion is an option to increase tumour control with potentially no additional toxicity. The application of a spacer is a promising concept for optimal protection of the rectal wall.

Please view the full content in the pdf above.